WO2004087630A1 - Process for producing cyclohexenone long-chain alcohols - Google Patents
Process for producing cyclohexenone long-chain alcohols Download PDFInfo
- Publication number
- WO2004087630A1 WO2004087630A1 PCT/JP2003/003994 JP0303994W WO2004087630A1 WO 2004087630 A1 WO2004087630 A1 WO 2004087630A1 JP 0303994 W JP0303994 W JP 0303994W WO 2004087630 A1 WO2004087630 A1 WO 2004087630A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mmol
- cyclohexen
- methyl
- cyclohexenone long
- chain alcohol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
- C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
- C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/713—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
Definitions
- the present invention relates to a process for producing a cyclohexenone long-chain alcohol, which process requires a reduced number of reaction steps and can be performed with ease and is thus industrially advantageous.
- Nerve growth factor which is found in particular abundance in the hippocampus and cerebral cortex of the brain, is a neurotrophic factor which is required by a living body for sustaining life and functions and stimulates differentiation and growth of neurons.
- NGF acts on cholinergic neurons. Alzheimer's disease is accepted to exhibit a primary lesion of regeneration and falling of cholinergic neurons, and on the basis of this understanding, NGF has been administered to the brain as therapy for the disease.
- NGF being a protein having a molecular weight of 12,000, cannot pass through the blood-brain barrier, and thus does not serve as practical means for the treatment of Alzheimer's disease.
- cyclohexenone long-chain alcohol has a low molecular weight and is known to be useful as a prophylactic or therapeutic drug for cerebral diseases such as dementia, in view that, when administered orally, the alcohol reaches the brain, passes through the blood-brain barrier, and at low concentration exhibits excellent effect to stimulate growth of neurons, to thereby directly act on neurites to elicit extension (Japanese Kohyo (PCT) Patent Publication No. 2U01- 515058) .
- cyclohexenone long-chain alcohol has been produced through a complicated process; for example, by reacting cyclohexanone or methyl-substituted 2-cyclohexen-l- one with benzenesulfinate in the presence of acid, then with ethylene glycol to form a ketal compound, and further with ⁇ -halogenoalcanol, followed by treatment with an acid to remove a protective group.
- cyclohexanone or methyl-substituted 2-cyclohexen-l- one with benzenesulfinate in the presence of acid, then with ethylene glycol to form a ketal compound, and further with ⁇ -halogenoalcanol, followed by treatment with an acid to remove a protective group.
- 3- (14-hydroxytetradecyl) -4-methyl-2-cyclohexen- 1-one from a starting material 3-methylcyclohexenone
- seven reaction steps have conventionally been required.
- an object of the present invention is to provide an industrially advantageous process for producing cyclohexenone long-chain alcohol, which process requires a reduced number of reaction steps and can be performed with ease ' and at reduced production cost.
- the present inventors have performed extensive studies for developing a simple, convenient process for producing cyclohexenone long-chain alcohol starting from a known substance, and have found that when cyclohexenone of enol form which can be produced with ease from a known substance 1, 3-cyclohexanedione is subjected to Grignard reaction by use of ⁇ -halogeno long-chain alcohol whose hydroxyl group is protected through silylation, cyclohexenone long-chain alcohol can be obtained through a reduced number of steps, conveniently, at low production cost, and in an industrially advantageous manner, thus leading to completion of the invention.
- the present invention provides a process for producing cyclohexenone long-chain alcohol represented by the following formula (1) :
- R 1 , R 2 , and R 3 have the same meanings as above, and R 4 represents a C1-C5 alkyl group
- a Grignard's reagent prepared from C10-C18 ⁇ -halogenoalcohol whose hydroxyl group is protected through silylation, and hydrolyzing the resultant reaction product.
- each of R 1 , R 2 , and R 3 represents a hydrogen atom.
- at least one of these is methyl.
- R 4 represents a C1-C5 alkyl, with ethyl being particularly preferred.
- Examples of preferred starting compound (2) include 3- ethoxy-6-methyl-2-cyclohexen-l-one, 3-ethoxy-2, 6-dimethyl-2- cyclohexen-1-one, and 3-methoxy-2, 6, ⁇ -trimethyl-2-cyclohexen- 1-one.
- the starting compound (2) can be obtained through enolation and methylation of 1, 3-cyclohexanedione, which is available at low cost.
- the sequence in which enolation and methylation are carried out is not critical, and enolation may precede methylation or vice versa.
- R 1 , R 2 , and R 3 are hydrogen atoms, methylation is not necessary.
- Enolation may be performed by reacting 1,3- cyclohexanedione, which may optionally be methylated if necessary (e.g., 2-methyl-l, 3-cyclohexanedione) , with alcohol (R 4 OH) in the presence of an acid catalyst.
- the acid catalyst include p-toluenesulfonic acid and sulfuric acid.
- the reaction is carried out in a solvent such as toluene, xylene, methanol, or ethanol, at 60-150°C for 2 to 10 hours.
- Methylation is performed by, for example, reacting enolated 1, 3-cyclohexanedione, which may optionally be enolated if necessary, with a lithiation reagent such as lithium diisopropylamide obtained through reaction between alkyl lithium and diisopropylamine, then with a methylation agent such as methyl iodide.
- a lithiation reagent such as lithium diisopropylamide obtained through reaction between alkyl lithium and diisopropylamine
- the lithiation reaction is preferably performed by cooling a solution prepared by adding lithium diisopropylamine to tetrahydrofuran or hexane to -80 to 0°C (e.g., -78°C) , then adding optionally enolated 1,3- ' cyclohexanedione (preferably 3-ethoxy-2-cyclohexan-l-one) dissolved in tetrahydrofuran, hexane, etc.
- methylation is performed after adding methyl iodide to the resultant reaction mixture and heating the mixture to 5 to 30°C (e.g., room temperature), while stirring the mixture for 5 to 12 hours.
- the thus-obtained compound (2) is reacted with a Grignard's reagent prepared from C10-C18 ⁇ -halogenoalcanol whose hydroxy group is protected through silylation, and is then subjected to hydrolysis, to thereby produce a cyclohexenone long-chain alcohol (1) .
- a Grignard's reagent prepared from C10-C18 ⁇ -halogenoalcanol whose hydroxy group is protected through silylation, and is then subjected to hydrolysis, to thereby produce a cyclohexenone long-chain alcohol (1) .
- Examples of the C10- C18 ⁇ -halogenoalcanol which has undergone silylation include the compound represented by the following formula (3) :
- R 5 , R 6 , and R 7 represents a C1-C8 alkyl group)'.
- X include Cl, Br, and I, with Br being preferred.
- A include C10-C18 linear or branched alkylene or alkenylene groups, with C12-C16 linear or branched alkylene groups being more preferred, and C12-C16 linear alkylene groups being even more preferred, and tetradecylene and pentadecylene being most preferred.
- R 5 , R 6 , and R 7 include a methyl group, an ethyl group, an isopropyl group, and a t-butyl group.
- the Grignard's reagent used in the present invention can be obtained by a conventional method, through reaction between a silylated ⁇ -halogenoalcanol and magnesium.
- the reaction between the compound (2) and the Grignard's reagent is performed in the manner of an ordinary Grignard reaction, and preferably in an absolute solvent such as diethyl ether or tetrahydrofuran at 40-80°C for 0.5 to 3 hours .
- the subsequent hydrolysis is preferably performed in the presence of an acid such as p-toluenesulfonic acid, hydrochloric acid, or sulfuric acid.
- an acid such as p-toluenesulfonic acid, hydrochloric acid, or sulfuric acid.
- the resultant intermediate may be isolated and then forwarded to the next reaction step.
- the intermediate may be forwarded directly to the next reaction step, without being isolated.
- the intermediate or a target compound can be isolated from a reaction mixture through washing, extraction, recrystallization, chromatographic techniques, etc., solely or in combination.
- methyl iodide (1.21 mL, 19.45 mmol) was added thereto, and the temperature of the reaction mixture was allowed to rise to room temperature.
- the reaction mixture was stirred overnight, diluted with water (100 mL) , and then extracted three times with ethyl ether. The organic layers were combined, washed with an aqueous NaCl solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
- Hydrogen bromide 50 L was gradually added to a mixture of 1, 15-pentadecanediol (5.08 g, 20.8 mmol) and cyclohexane (50 mL) , and the resultant mixture was refluxed with heat for 6 hours, followed by separation into two layers, The aqueous layer was subjected to extraction with hexane three times. The organic layers were combined, washed with aqueous saturated sodium hydrogencarbonate solution and aqueous sodium chloride solution, dried over magnesium sulfate, and concentrated under reduced pressure.
- the mixture was stirred for one hour at room temperature.
- aqueous saturated ammonium chloride solution was added to the reaction mixture for separation into a methylene chloride layer (200 mL) and an aqueous layer (200 . mL) .
- the organic layer was dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
- the reaction mixture was neutralized with sodium hydrogencarbonate, followed by extraction with ethyl ether three times.
- the organic layers were combined, washed with aqueous sodium chloride solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
- methyl iodide (0.77 mL, 12.4 mmol) was added, and the temperature of the reaction mixture was allowed to rise to room temperature. The reaction mixture was stirred for 18 hours at room temperature. Water (100 mL) was added thereto, and the resultant mixture was subjected to extraction three times with ethyl ether. The organic layers were combined, washed with an aqueous NaCl solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
- the process of the present invention for producing cyclohexenone long-chain alcohol involves a reduced number of reaction steps, can be performed with ease at reduced production cost, and thus finds utility in the industry.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2003/003994 WO2004087630A1 (en) | 2003-03-28 | 2003-03-28 | Process for producing cyclohexenone long-chain alcohols |
CA002519178A CA2519178C (en) | 2003-03-28 | 2003-03-28 | Process for producing cyclohexenone long-chain alcohols |
US10/550,305 US7235700B2 (en) | 2003-03-28 | 2003-03-28 | Process for producing cyclohexenone long-chain alcohols |
DE60319439T DE60319439T2 (en) | 2003-03-28 | 2003-03-28 | METHOD FOR THE PRODUCTION OF LONG-CHAIN CYCLOHEXENONAL COLKS |
EP03715611A EP1608612B1 (en) | 2003-03-28 | 2003-03-28 | Process for producing cyclohexenone long-chain alcohols |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2003/003994 WO2004087630A1 (en) | 2003-03-28 | 2003-03-28 | Process for producing cyclohexenone long-chain alcohols |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004087630A1 true WO2004087630A1 (en) | 2004-10-14 |
Family
ID=33105315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/003994 WO2004087630A1 (en) | 2003-03-28 | 2003-03-28 | Process for producing cyclohexenone long-chain alcohols |
Country Status (5)
Country | Link |
---|---|
US (1) | US7235700B2 (en) |
EP (1) | EP1608612B1 (en) |
CA (1) | CA2519178C (en) |
DE (1) | DE60319439T2 (en) |
WO (1) | WO2004087630A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180108669A (en) * | 2016-01-22 | 2018-10-04 | 다이호야쿠힌고교 가부시키가이샤 | Process for producing high purity cyclohexenone long-chain alcohol |
RU2745062C2 (en) * | 2016-02-03 | 2021-03-18 | Тайхо Фармасьютикал Ко., Лтд. | Producing method of long-chain alcohol of high purity cyclohexenone |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000047199A1 (en) * | 1999-02-10 | 2000-08-17 | Meiji Dairies Corporation | Use of a cyclohexenone long-chain alcohol for treating neurodegenerative diseases |
JP2001089404A (en) * | 1999-09-22 | 2001-04-03 | Meiji Milk Prod Co Ltd | Cyclohexenol derivative and medicine comprising the same |
JP2003212811A (en) * | 2002-01-22 | 2003-07-30 | Meiji Milk Prod Co Ltd | Method for producing cyclohexenone long-chain alcohol |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2299308C (en) * | 1997-08-13 | 2008-03-25 | Meiji Milk Products Co., Ltd. | Cyclohexenone long-chain alcohol and medicament containing same |
ATE450602T1 (en) * | 2000-10-04 | 2009-12-15 | Meiji Dairies Corp | STEM CELL DIFFERENTIATION-INDUCING PROMOTERS |
JP4861560B2 (en) * | 2001-02-19 | 2012-01-25 | 株式会社明治 | Treatment for diabetic complications |
JP3836684B2 (en) * | 2001-02-19 | 2006-10-25 | 明治乳業株式会社 | Treatment for dysuria |
WO2002094252A1 (en) | 2001-05-24 | 2002-11-28 | Meiji Dairies Corporation | Preventive or remedy for diseases caused by cerebrovascular disturbances |
US20040152766A1 (en) * | 2001-05-31 | 2004-08-05 | Au-Yeung Steven C.F. | Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof |
-
2003
- 2003-03-28 US US10/550,305 patent/US7235700B2/en not_active Expired - Lifetime
- 2003-03-28 CA CA002519178A patent/CA2519178C/en not_active Expired - Lifetime
- 2003-03-28 DE DE60319439T patent/DE60319439T2/en not_active Expired - Lifetime
- 2003-03-28 WO PCT/JP2003/003994 patent/WO2004087630A1/en active IP Right Grant
- 2003-03-28 EP EP03715611A patent/EP1608612B1/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000047199A1 (en) * | 1999-02-10 | 2000-08-17 | Meiji Dairies Corporation | Use of a cyclohexenone long-chain alcohol for treating neurodegenerative diseases |
JP2001089404A (en) * | 1999-09-22 | 2001-04-03 | Meiji Milk Prod Co Ltd | Cyclohexenol derivative and medicine comprising the same |
JP2003212811A (en) * | 2002-01-22 | 2003-07-30 | Meiji Milk Prod Co Ltd | Method for producing cyclohexenone long-chain alcohol |
Non-Patent Citations (3)
Title |
---|
CHEMICAL ABSTRACTS, vol. 134, Columbus, Ohio, US; abstract no. 261264, LUU, BANG ET AL: "Nerve cell growth-promoting cyclohexenols and pharmaceuticals containing them" XP002262863 * |
MORI, KENJI ET AL: "Synthesis of sphingosine relatives. X. Synthesis of (2S, 3R, 4E)-1-O-(.beta.-D-glucopyranosyl)-N-[30'- (linoleoyloxy)triacontanoyl]-4-icosasphingenine, a new esterified cerebroside isolated from human and pig epidermis", LIEBIGS ANNALEN DER CHEMIE (1991), (6), 529-35, XP002262862 * |
PATENT ABSTRACTS OF JAPAN vol. 2003, no. 11 5 November 2003 (2003-11-05) * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180108669A (en) * | 2016-01-22 | 2018-10-04 | 다이호야쿠힌고교 가부시키가이샤 | Process for producing high purity cyclohexenone long-chain alcohol |
JP2019504079A (en) * | 2016-01-22 | 2019-02-14 | 大鵬薬品工業株式会社 | Method for preparing high purity cyclohexenone long chain alcohol |
EP3406586A4 (en) * | 2016-01-22 | 2019-09-11 | Taiho Pharmaceutical Co., Ltd. | Manufacturing method for high-purity cyclohexenone long-chain alcohol |
RU2729186C2 (en) * | 2016-01-22 | 2020-08-05 | Тайхо Фармасьютикал Ко., Лтд. | Method of producing high-purity long-chain cyclohexenone alcohol |
AU2017209644B2 (en) * | 2016-01-22 | 2020-08-13 | Taiho Pharmaceutical Co., Ltd. | Manufacturing method for high-purity cyclohexenone long-chain alcohol |
TWI728042B (en) * | 2016-01-22 | 2021-05-21 | 日商大鵬藥品工業股份有限公司 | Method for preparing high-purity cyclohexenone long-chain alcohol |
KR102387362B1 (en) * | 2016-01-22 | 2022-04-15 | 다이호야쿠힌고교 가부시키가이샤 | Method for producing high-purity cyclohexenone long-chain alcohol |
US11485696B2 (en) | 2016-01-22 | 2022-11-01 | Taiho Pharmaceutical Co., Ltd. | Manufacturing method for high-purity cyclohexenone long-chain alcohol |
RU2745062C2 (en) * | 2016-02-03 | 2021-03-18 | Тайхо Фармасьютикал Ко., Лтд. | Producing method of long-chain alcohol of high purity cyclohexenone |
Also Published As
Publication number | Publication date |
---|---|
EP1608612A1 (en) | 2005-12-28 |
CA2519178C (en) | 2010-01-12 |
CA2519178A1 (en) | 2004-10-14 |
US20060135818A1 (en) | 2006-06-22 |
US7235700B2 (en) | 2007-06-26 |
EP1608612B1 (en) | 2008-02-27 |
DE60319439T2 (en) | 2008-06-19 |
DE60319439D1 (en) | 2008-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Corey et al. | Total synthesis of erythromycins. 5. Total synthesis of erythronolide A | |
JP2668759B2 (en) | Intermediate for synthesis of 19-nor-vitamin D compound | |
DK2714710T3 (en) | A process for the preparation of intermediates estetrol | |
JPH06172302A (en) | Preparation of 19- nor vitamin d compound | |
Marshall et al. | Total synthesis of (+-)-isonootkatone. Stereochemical studies of the Robinson annelation reaction with 3-penten-2-one | |
Johnson et al. | Biomimetic polyene cyclizations. Participation of the (trimethylsilyl) acetylenic group and the total synthesis of the D-homosteroid system | |
Marshall et al. | Stereocontrolled total synthesis of. alpha.-and. beta.-santonin | |
EP1608612B1 (en) | Process for producing cyclohexenone long-chain alcohols | |
CA2107471C (en) | Fluorine-containing vitamin d3 analogues | |
JP2000504335A (en) | Biphenyl compounds and their use as estrogenic agents | |
Hwu et al. | Silicon-directed decarbonylation of trimethylsilyl. beta.,. gamma.-enals by photolysis | |
JP4035332B2 (en) | Process for producing cyclohexenone long chain alcohols | |
JP2793428B2 (en) | Method for preparing 1α-hydroxy-secosterol compound | |
Cohen et al. | Carbene anion formation from a dithioacetal anion bearing an allylic oxyanion substituent at the 2 position. Divergent behavior of the dianion in ether and THF | |
CN114560753B (en) | Process for preparing hydroxy epoxy analogues | |
Hassner et al. | Stereochemistry. XXXIX. Hydroboration of enol acetates | |
AU648073B2 (en) | Cytotoxic bicyclo(7.3.1)tridec-4-ene-2,6-diyne compounds and process for the preparation thereof | |
Hojo et al. | Diphenylsilane reduction of C= O and C= N bearing electron-withdrawing group in the presence of aluminum (III) chloride. | |
Haddadpour | Studies toward Total Synthesis of Cyathane Diterpenoids | |
JP2680231B2 (en) | Process for producing optically active 24-hydroxycholesterols | |
JP2975704B2 (en) | Steroid derivatives | |
JPH07126246A (en) | New intermediate for producing vitamin d derivative | |
Santiago et al. | A Synthesis of 2, 2-Ethylenedioxy-6-ketones | |
Boukherroub et al. | Unprecedented effects of the trimethylsilyl group on the reactivity of 3C-silylated silacyclopentenes and their derivatives | |
JPS61152675A (en) | Production of dibenzo(b,e)oxepine derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003715611 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2519178 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2006135818 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10550305 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2003715611 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10550305 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 2003715611 Country of ref document: EP |